Johnson & Johnson (JNJ): I Would “Love” If Trump Praised The Company, Says Jim Cramer
Johnson & Johnson (NYSE:JNJ) is one of the largest and most well-known pharmaceutical companies in the world.
Posts Tagged ‘Johnson & Johnson (NYSE:JNJ)’
14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the recent Bitcoin price jumps.
Johnson & Johnson Submits Schizophrenia Drug CAPLYTA sNDA to FDA Based on Positive Relapse Prevention Data
Johnson & Johnson (NYSE:JNJ) is one of the most undervalued NYSE stocks to buy now.
12 Most Undervalued NYSE Stocks to Buy Now
On July 8, Brenda Vingiello, Sand Hill Global Advisors' CIO joined 'Closing Bell Overtime' on CNBC to talk about the day's market action.
Johnson & Johnson (JNJ) Applied to the European Medicines Agency to Expand AKEEGA Usage
Johnson & Johnson (NYSE:JNJ) is one of the 10 Best Non-Tech Stocks to Buy and Hold For 3 Years. On July 3, Janssen-Cilag, a company of Johnson & Johnson (NYSE:JNJ), reported...
10 Best Non-Tech Stocks to Buy and Hold For 3 Years
On July 4, Scott Bessent, US Treasury Secretary, gave a statement noting that the market resilience has shown that the tariffs haven’t hurt the economy.
J.P. Morgan Maintained Their Hold Rating on Johnson & Johnson (JNJ)
Johnson & Johnson (NYSE:JNJ) is one of the 10 Best Dip Stocks to Buy According to Billionaires. On June 26, J.P.
Goldman Sachs Rates Johnson & Johnson a Buy, Citing Pipeline Strength and Policy Tailwinds
Johnson & Johnson (NYSE:JNJ) ranks among the best set-it-and-forget-it stocks to buy.
10 Best Dip Stocks to Buy According to Billionaires
On July 3rd, Dan Ives, Global Head of Tech Research at Wedbush, joined CNBC to discuss the technology sector.
15 Set-It-and-Forget-It Stocks to Buy According to Analysts
As expectations for trade agreements and potential rate cuts reduced investor anxiety, the S&P 500 and Nasdaq reached record closing highs on June 30, concluding their strongest...
Johnson & Johnson’s (JNJ) IMAAVY Demonstrates Superior gMG Control
Johnson & Johnson (NYSE:JNJ) is one of the 12 stocks that will make you rich in 10 years. On June 23, J&J announced new data from an indirect treatment comparison (ITC) study.
12 Stocks That Will Make You Rich in 10 Years
One of the most read (and recommended) books on investing is Benjamin Graham’s The Intelligent Investor.
Why JNJ Is a Long-Term Winner
Johnson & Johnson (NYSE:JNJ) is a long-established leader in the healthcare industry, with a strong portfolio of high-performing drugs in areas like immunology and cancer treatment...
Johnson & Johnson CAR T Therapy Shows 80% Response in Lymphoma Trial
Johnson & Johnson (NYSE:JNJ) ranks among the top stocks for an early retirement portfolio.
Johnson & Johnson (JNJ) Launches Two New Plating Systems in the US
Johnson & Johnson (NYSE:JNJ) is one of the 10 Best and Cheap Stocks to Buy Now.
Johnson & Johnson MedTech Expands VOLT Platform With New Wrist, Upper Arm Fracture Systems
Johnson & Johnson (NYSE:JNJ) is one of the best Fortune 500 stocks to buy according to billionaires.
10 Best Wide Moat Dividend Stocks to Invest in
Wide-moat stocks refer to companies that possess lasting competitive strengths, helping them stay ahead of rivals.
J&J (JNJ) Faces $8M Verdict Over Talc Case; Stock Still Gains 4.66% YTD
Johnson & Johnson (NYSE:JNJ) is one of the 10 undervalued blue chip stocks analysts recommend for smart investing.
Early Retirement Portfolio: Top 15 Stock Picks
This week, Federal Reserve officials have the opportunity to discuss their views on interest rate trends, the effects of tariffs, and the economic effects of the Middle East crisis...
12 Best Fortune 500 Stocks to Buy According to Billionaires
On June 18, Jason Hunter, JPMorgan's head of technical strategy, joined CNBC's 'Closing Bell' to discuss how he believes that there's a bias for the market to correct over the...
10 Best and Cheap Stocks to Buy Now
On June 4 Morningstar released its June 2025 outlook, indicating that as of May 30, the US stock market was trading at a 3% discount to its fair value.
JNJ’s Consistent Payout Makes It a Top Pick for Down Markets
The company is facing a combination of slow revenue growth, unresolved legal battles over talc products, and looming drug price negotiations under new Medicare rules.
10 Undervalued Blue Chip Stocks Analysts Recommend for Smart Investing
Blue-chip stocks are great assets for investors looking for opportunities to grow their capital in the long term. Some call them steady oaks in the forest of finance.
10 Best Dividend Stocks for a Bear Market
According to Ned Davis Research, the broader market is now less than 3% below its all-time high from February, and only a recession would likely cause a significant pullback.
Johnson & Johnson (JNJ) Announces Results for Phase 3b APEX Study
Johnson & Johnson (NYSE:JNJ) is one of the 10 Cheapest High-Quality Stocks to Buy According to Hedge Funds.
UBS Backs Johnson & Johnson as a Defensive Play in Uncertain Times
On June 12, UBS global equity strategist Andrew Garthwaite’s team pointed to Johnson & Johnson as one of the top cyclical picks, excluding financials, whose performance tends...
Retirement Stock Portfolio: 10 Safe Dividend Stocks to Buy Now
Dividend-paying stocks are often considered a dependable option for retirement portfolios.
10 Cheapest High Quality Stocks to Buy According to Hedge Funds
On June 4, Jurrien Timmer, director of Global Macro for Fidelity Management & Research Company released his commentary on the stock market outlook.
Judge Orders J&J Subsidiary to Pay $442 Million in Antitrust Lawsuit
Recently, a federal judge ruled that a Johnson & Johnson subsidiary must pay $442 million in damages after a jury concluded last month that the company had broken antitrust laws...
Dow 20 Stocks List: Ranked By Hedge Fund Bullishness Index
The Dow Jones Industrial Average, often called the Dow Jones or just the Dow, is a stock market index that tracks 30 major publicly traded companies in the United States.
US FDA Votes in Favor of Benefit-Risk Profile of Johnson & Johnson’s DARZALEX FASPRO
On May 20, Johnson & Johnson (NYSE:JNJ) announced that the FDA Oncologic Drugs Advisory Committee/ODAC voted 6-2 in favor of the benefit-risk profile of single-agent DARZALEX ...
Jim Cramer Notes That “People Are Staying Away From” Johnson & Johnson
“Or let's consider Johnson & Johnson, triple A balance sheet, many drugs in the pipeline, one of the best-run companies in America, if not the world, with perhaps the most billion...
Jim Cramer Commented on 7 Hard-to-Own Safety Stocks
“When interest rates go up, even if they go up just a little, you can see lots of very good well-known stocks with juicy dividends just get pummeled.
13 Best Cheap Stocks to Invest in for Beginners
The last time the S&P erased a 15% decline in under six weeks was 1982, which tells a lot about the current market dynamics we are currently in.
Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries.
10 Best Income Stocks to Invest in Now
Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional defensive strategy.
11 Best Medical Device Stocks to Buy Now
On April 16, CNBC reported that Trump's tariffs are building a divide in the medical community.
ChatGPT Stock Advice: Top 12 Stock Recommendations
This article looks at ChatGPT Stock Advice: Top 12 Stock Recommendations.
Did Jim Cramer Hit or Miss On These 13 Stock Predictions?
“Alright, look, lately, we can’t go a day without hearing some widespread misperceptions about stock ownership. I gotta tell you, I think it’s infuriating.
10 Most Profitable Cheap Stocks to Buy Now
US stocks rose on Friday, May 2, as the S&P 500, Dow Jones Industrial Average, and the tech-heavy Nasdaq all posted impressive gains.
Jim Cramer Reveals Details Of Trump’s Tariff Negotiations & Discusses 10 Stocks
In his recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on the supply chain disruption that firms were facing and planning for in the wake of President Trump...
The Best and Worst Dow Stocks for the Next 12 Months
The Dow Jones Industrial Average (DJIA), or the Dow, is a price-weighted index that has long been seen as a barometer of the health of the U.S. economy.
10 Best Long-Term Dividend Stocks to Buy According to Billionaires
Dividend stocks are increasingly popular with both every day and billionaire investors.
Top 10 Stocks to Watch as Investors Brace for Recession
Despite some optimism in the market after President Donald Trump’s indication of possible talks with China, Wall Street analysts are warning about recession risks due to the...
10 Stocks Analysts are Talking About Amid Trump’s Tariff War
Markets saw some glimmer of hope as President Donald Trump indicated that he does not plan to fire Federal Reserve Chair Jerome Powell and showed openness to engage in talks with...
10 Most Profitable Blue Chip Stocks to Buy Now
Blue chip stocks are large, financially stable companies with strong market presence, consistent profitability, and regular dividend payments.
11 Best Safe Stocks to Buy According to Hedge Funds
In times when you never know what you’ll wake up to the next morning, playing safe seems to be the wisest choice.
Jim Cramer Says Trump’s Fed Chair Tussle Is Like “The Godfather” & Discusses These 10 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed whether President Trump could fire the chairman of the Federal Reserve, Jerome Powell.
13 Best American Dividend Stocks to Buy According to Analysts
Dividend-paying stocks have long benefited investors by delivering consistent and solid returns.
10 Best Low Volatility Stocks to Buy Now
The US stock market experienced a turbulent first quarter of 2025, marked by increased volatility and negative returns across the major indices.
